International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 2 : 664-667
Research Article
To determine role of clinical cardiological evaluation and ECG in associated left ventricular disease among COPD patients
 ,
 ,
Received
Feb. 26, 2026
Accepted
March 6, 2026
Published
March 14, 2026
Abstract

Background: - The present study was planned to determine role of clinical cardiological evaluation and ECG in associated left ventricular disease among COPD patients.

Introduction:-These patients usually respond to oxygen (O2) therapy, bronchodilators and antibiotics. However left ventricular (LV) dysfunction has been observed by several workers among such patients.

Material & Methods: - The present study included all diagnosed case of COPD of both gender, above the age of 40 years, attending outdoor and indoor of the department of respiratory medicine, the stipulated period, after considering the inclusion and exclusion criteria.

Statistical Analysis: - Statistical analysis was performed using SPSS version 20. All the data were presented as mean ±SD for continuous variables and percentage for categorical variables. A comparison was done between variables using independent students ‘t’- test.

Results: - The correlation between radiological finding of chest and the prevalence of LV diastolic dysfunction. Radiological findings of LV diastolic dysfunction was observed in 236 out of 257 (91.83%) cases with hyperinflated lung in CXR, whereas it was 71 out of 98 (72.42%) in patients with prominent broncho-vascular marking in CXR. There was no significant relation between chest x-ray findings and LV diastolic dysfunction. (P = > 0.05).

Conclusion: - In our study we found dyspnea to be the predominant symptom. Although some studies indicated a weak relationship between the symptoms of dyspnea as a indicator of disease severity and left ventricular ejection fraction (FEV1, LVEF). But some other studies did not find any such corelationship. We too did not find any significant association between this predominant symptom of dyspnea and LV diastolic dysfunction.

Keywords
INTRODUCTION

The persistent airways obstruction in older chronic asthmatics is often difficult or even impossible to differentiate from that in COPD, although a history of heavy cigarette smoking, evidence of emphysema by imaging techniques, decreased diffusing capacity for carbon monoxide and chronic hypoxemia favor a diagnosis of COPD1. However left ventricular (LV) dysfunction has been observed by several workers among such patients. The ratio of LV dysfunction, alternative to ischemic heart disease (IHD), is likely higher in COPD patients because it portion many danger factors with coronary disease like age, male predomination, cigarette smoky etc.2

 

MATERIAL & METHODS

Study Area

Department of Respiratory Medicine, Dr. Ulhas Patil Medical College and Hospital, Jalgaon

 

Study Population

Each known case of COPD of some gender, preceding the age of 40 years, being outdoor and indoor of the department of respiratory medicine, Dr. Ulhas Patil Medical College and Hospital, Jalgaon over the stipulated period, after considering the inclusion and exclusion criteria.

 

Study Design

Observational cross-sectional study.

 

Statistical Analysis:-

Statistical analysis was performed using SPSS. Each the information were given as mean + SD for uninterrupted variant and proportion for accumulation changeable. A comparison was done between changeable using independent students ‘t’-test. A p-value.  A p-value <0.05 was considered as statistically significant.

 

RESULTS

 

Table 1:- Shows chest X-ray finding of the study population.

X-RAY CHEST FINDINGS

NO. OF PATIENTS

PERCENTAGE

Hyper-inflated lung

257

72%

Prominent bronchovascular markings

98

28%

 

Our study was shown in table-1. Chest Xray (CXR) showed hyper-inflated lung in 257 (72%) cases and prominent bronchovascular marking in 98 (28%) cases. Other radiological findings were bulla found in (43, 12%), hilar prominence (28,8%), tubular heart (28,12%), right ventricular enlargement (28,8%) and low flat diaphragm (50,14%).

 

Table 2:- Showing the ECG findings in the study population.

ECG FEATURES

NO. OF PATIENTS

PERCENTAGE

P pulmonale

221

62%

Low voltage complex

57

16%

Normal

77

22%

 

 Our study were P-pulmonale was found in 221(62%) cases, low voltage complex was found in 57(16%) cases, right bundle brunch block pattern was noted in (28,8%) and ECG picture of right ventricular hypertrophy was observed in (7,2%) case. In 77 (22%) cases ECG was normal. We did not get arrhythmia in any case. P-pulmonale was the predominant ECG finding in our study, and that signified right atrial enlargement as a result of RV hypertrophy secondary to pulmonary arterial hypertension in COPD.

 

Table 3:- Showing correlation between X-ray chest finding and LV diastolic dysfunction

X-RAY CHEST FINDING

NO .OF PATIENTS

LEFT VEBTRICULAR

DIASTOLIC DYSFUNCTION

PERCENTAGE

 

Hyper-inflated lung

257

236

91.83%

Prominent broncho-vascular marking

98

71

72.45%

 

We analyzed the correlation between radiological finding of chest and the prevalence of LV diastolic dysfunction. Radiological findings of LV diastolic dysfunction was observed in 236 out of 257 (91.83%) cases with hyperinflated lung in CXR, whereas it was 71 out of 98 (72.42%) in patients with prominent broncho-vascular marking in CXR. The calculated χ² was 1.73 and P was 0.18. So, there was no significant relation between chest x-ray findings and LV diastolic dysfunction. (P = > 0.05).

 

DISCUSSION

We have assessed left ventricular function in COPD patients and have found that majority of them have LV diastolic dysfunction and that is statistically highly significant (p< 0.05). In our study we recovered dyspnea to be the frequent symptom. Although some studies signal a weak relation between the symptoms of dyspnea as a index of disease severity and left ventricular expulsion fraction (FEV1, LVEF).3 But some other studies did not find any such corelationship4-5. We too did not find any significant association between this predominant symptom of dyspnea and LV diastolic dysfunction (p>0.05)

 

We determined that there was addition prevalence of LV diastolic dysfunction in our subset of patients, but only one patient had systolic dysfunction which was not important statistically. We could not found the cause of systolic dysfunction in one patient as we excluded patients with myocardial infarction, ischaemic heart disease, cardiomegaly, valvular heart disease and hypertensive heart disease. To find out hidden ischaemic heart disease or myocardial disease, cardiac catheterization, coronary angiography or myocardial biopsy were necessary but those procedures were not included in our study. A. K. Podder et al6 according constant of LV systolic function like EF, was down in the subset of patients of COPD with corpulmonale. However we did not find any such co-relation.

 

CONCLUSION

We recovered 2 % cases with low EF, and the mean EF was (67%) with standard deviation SD (7%). No patient in my study had abnormal ventricular wall movement. For assessment of LV diastolic function I recorded early rapid filling phage /late rapid filling phage (E/A), deceleration time (DT) and is volumetric relaxation time (IVRT). We noted low E/A ratio (normal: 1-1.5) in 84% cases, and the mean E/A ratio was 0.92 with SD 0.20. We recovered accrued DT in 84% cases with mean 247.42 ± 18.76. IVRT was accrued in 84% cases with mean 96.78 ± 8.44. Left ventricular diastolic dysfunction was noted in 84% proceeding and both systolic and diastolic dysfunction was listed in 2% case. Separated systolic dysfunction was not recovered in the examination. 48 patients had normal echocardiography.

 

REFERENCES

  1. American Thoracic Society. Standards and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995:152:S77.
  2. Sin DD, McAlister FA, Man SPF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003; 290:2301-2312.
  3. Wijnhoven HA, Kriegsman DM, Hesselink AE, pennix BW, de Haan M. Determination of different dimensions of disease severity in asthma and COPD: pulmonary function and health-related quality of life .Chest 2001; 119:1034-1042.
  4. Aronld R, Ranchor AV, Koeter GH, Jongste MJ, Sanderman R. Consequences of chronic obstructive pulmonary disease and chronic heart failure: the relationship between objective health. Soc Sci Med 2005; 61:2144-2154.
  5. Rector TS, Anand IS, Cohn JN. Relationship between clinical assessment and patients of the effect of heart failure on their quality of life .J Card Fail 2006;2:87-23.Lung Heart Study Research Group. Effect of inhaled triamcinolone on decline in pulmonary function in chronic obstructive pulmonary disease. N Engl j Med 2000; 343:1902-1909.
  6. A.K Poddar, BN. Chakraborti, J.L. Ghosh,S. Nandy and S.Hazra. Indian Journal of Tuberculosis. 1997.44.181. 
Recommended Articles
Original Article Open Access
Arthroscopic Dual-Tunnel Fixation of Anterior Cruciate Ligament Tibial Avulsion Fractures Using a Luggage-Tag FiberWire Configuration
2026, Volume-7, Issue 2 : 722-727
Original Article Open Access
Impact of Dense Breast Tissue on Mammographic Sensitivity and the Role of Adjunct Ultrasound
2024, Volume-5, Issue-5 : 332-339
Original Article Open Access
Impact of COVID-19 Pandemic on Breast Cancer Screening and Staging at Diagnosis: A Retrospective Study
2024, Volume-5, Issue-4 : 236-241
Research Article Open Access
Evaluation of the Efficacy of Two Different Doses of Dexamethasone as an Adjuvant To 0.5% Levobupivacaine in Ultrasonic Guided Supraclavicular Brachial Plexus Block
2026, Volume-7, Issue 2 : 706-709
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 2
Citations
19 Views
22 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved